Skip to content
2000
Volume 2, Issue 1
  • ISSN: 1573-3947
  • E-ISSN: 1875-6301

Abstract

Survivin is a relatively unique member of the inhibitor of apoptosis protein (IAP) family. It contains a single baculovirus IAP repeat (BIR) domain. It is involved in the control of cell cycle and inhibition of apoptosis. Survivin is of interest because it is specifically up-regulated in cancer cells and completely down-regulated and undetectable in normal adult tissues. Thus, survivin has proved to be a promising therapeutic target for normal anti-cancer therapy. Survivin protects the fast dividing tumor cells against default apoptosis to facilitate aberrant mitosis. Down-regulation of survivin with multiple approaches, suppress tumor progression and induce apoptosis on its own or in combination with chemotherapy and radiotherapy.

Loading

Article metrics loading...

/content/journals/cctr/10.2174/157339406777592113
2006-02-01
2025-05-20
Loading full text...

Full text loading...

/content/journals/cctr/10.2174/157339406777592113
Loading

  • Article Type:
    Research Article
Keyword(s): Apoptosis; Caspases; IAPs; p53; Ribozyme; Survivin
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test